Mauricio Torres

Mauricio Torres

Auto-generated profile, based on publicly available information

Mauricio Torres

Department of Molecular Physiology and Biological Physics, University of Virginia School of Medicine

Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 March 2020 in Science
Verified
Journal Article
Closed access
PDF file
ZZZhangsen Zhou
Zhangsen Zhou
MTMauricio Torres
Mauricio Torres
HSHaibo Sha
Haibo Sha
CHChristopher J. Halbrook
Christopher J. Halbrook
FBFrançoise Van Den Bergh
Françoise Van Den Bergh
LQLing Qi
Ling Qi
The endoplasmic reticulum (ER) engages mitochondria at specialized ER domains known as mitochondria-associated membranes (MAMs). Here, we used three-dimensional high-resolution imaging to investigate the formation of pleomorphic “megamitochondria” with altered MAMs in brown adipocytes lacking the Sel1L-Hrd1 protein complex of ER-associated protein degradation (ERAD). Mice with ERAD deficiency in brown adipocytes were cold sensitive and exhibited mitochondrial dysfunction. ERAD deficiency affected ER-mitochondria contacts and mitochondrial dynamics, at least in part, by regulating the turnover of the MAM protein, sigma receptor 1 (SigmaR1). Thus, our study provides molecular insights into ER-mitochondrial cross-talk and expands our understanding of the physiological importance of Sel1L-Hrd1 ERAD.

1 May 2008 in Current Molecular Medicine
Verified
Journal Article
Closed access
PDF file
SMSoledad Matus
Soledad Matus
FLFernanda Lisbona
Fernanda Lisbona
MTMauricio Torres
Mauricio Torres
CLCristian Leon
Cristian Leon
PTPeter Thielen
Peter Thielen
CHClaudio Hetz
Claudio Hetz
The unfolded protein response (UPR) is a conserved adaptive reaction that increases cell survival under conditions of endoplasmic reticulum (ER) stress. The UPR controls diverse processes such as protein folding, secretion, ER biogenesis, protein quality control and macroautophagy. Occurrence of chronic ER stress has been extensively described in neurodegenerative conditions linked to protein misfolding and aggregation, including Amyotrophic lateral sclerosis, Prion-related disorders, and conditions such as Parkinsons, Huntingtons, and Alzheimers disease. Strong correlations are observed between disease progression, accumulation of protein aggregates, and induction of the UPR in animal and in vitro models of neurodegeneration. In addition, the first reports are available describing the engagement of ER stress responses in brain postmortem samples from human patients. Despite such findings, the role of the UPR in the central nervous system has not been addressed directly and its contribution to neurodegeneration remains speculative. Recently, however, pharmacological manipulation of ER stress and autophagy – a stress pathway modulated by the UPR – using chemical chaperones and autophagy activators has shown therapeutic benefits by attenuating protein misfolding in models of neurodegenerative disease. The most recent evidence addressing the role of the UPR and ER stress in neurodegenerative disorders is reviewed here, along with therapeutic strategies to alleviate ER stress in a disease context.

21 July 2012 in FEBS Letters
Verified
Journal Article
Open access
CACatherine I. Andreu
Catherine I. Andreu
UWUte Ute Woehlbier
Ute Ute Woehlbier
MTMauricio Torres
Mauricio Torres
CHClaudio Hetz
Claudio Hetz
Protein disulfide isomerases (PDIs) are a family of foldases and chaperones primarily located at the endoplasmic reticulum that catalyze the formation and isomerization of disulfide bonds thereby facilitating protein folding. PDIs also perform important physiological functions in protein quality control, cell death, and cell signaling. Protein misfolding is involved in the etiology of the most common neurodegenerative diseases, including Alzheimer, Parkinson, amyotrophic lateral sclerosis, Prion‐related disorders, among others. Accumulating evidence indicate altered expression of PDIs as a prominent and common feature of these neurodegenerative conditions. Here we overview most recent advances in our understanding of the possible functional contribution of PDIs to neurodegeneration, depicting a complex and poorly understood scenario. Possible therapeutic benefits of targeting PDIs in a disease context and their use as biomarkers are discussed.

11 February 2016 in The EMBO Journal
Verified
Journal Article
Open access
PDF file
UWUte Ute Woehlbier
Ute Ute Woehlbier
ACAlicia Colombo
Alicia Colombo
MSMirva Saaranen
Mirva Saaranen
VPViviana Pérez
Viviana Pérez
JOJorge Ojeda
Jorge Ojeda
CHClaudio Hetz
Claudio Hetz
EMBO Press is an editorially independent publishing platform for the development of EMBO scientific publications.

1 July 2020 in Journal of Clinical Investigation
Verified
Journal Article
Open access
PDF file
NSNeha Shrestha
Neha Shrestha
TLTongyu Liu
Tongyu Liu
YJYewei Ji
Yewei Ji
Rachel Byerley ReinertRachel Byerley Reinert
Rachel Byerley Reinert
MTMauricio Torres
Mauricio Torres
LQLing Qi
Ling Qi
β Cell apoptosis and dedifferentiation are 2 hotly debated mechanisms underlying β cell loss in type 2 diabetes; however, the molecular drivers underlying such events remain largely unclear. Here, we performed a side-by-side comparison of mice carrying β cell–specific deletion of ER-associated degradation (ERAD) and autophagy. We reported that, while autophagy was necessary for β cell survival, the highly conserved Sel1L-Hrd1 ERAD protein complex was required for the maintenance of β cell maturation and identity. Using single-cell RNA-Seq, we demonstrated that Sel1L deficiency was not associated with β cell loss, but rather loss of β cell identity. Sel1L-Hrd1 ERAD controlled β cell identity via TGF-β signaling, in part by mediating the degradation of TGF-β receptor 1. Inhibition of TGF-β signaling in Sel1L-deficient β cells augmented the expression of β cell maturation markers and increased the total insulin content. Our data revealed distinct pathogenic effects of 2 major proteolytic pathways in β cells, providing a framework for therapies targeting distinct mechanisms of protein quality control.

29 December 2010 in PLOS ONE
Verified
Journal Article
Open access
PDF file
MTMauricio Torres
Mauricio Torres
KCKaren Castillo
Karen Castillo
RARicardo Armisén
Ricardo Armisén
ASAndrés Stutzin
Andrés Stutzin
Claudio SotoClaudio Soto
Claudio Soto
CHClaudio A. Hetz
Claudio A. Hetz
Prion-related disorders (PrDs) are fatal neurodegenerative disorders characterized by progressive neuronal impairment as well as the accumulation of an abnormally folded and protease resistant form of the cellular prion protein, termed PrPRES. Altered endoplasmic reticulum (ER) homeostasis is associated with the occurrence of neurodegeneration in sporadic, infectious and familial forms of PrDs. The ER operates as a major intracellular calcium store, playing a crucial role in pathological events related to neuronal dysfunction and death. Here we investigated the possible impact of PrP misfolding on ER calcium homeostasis in infectious and familial models of PrDs. Neuro2A cells chronically infected with scrapie prions showed decreased ER-calcium content that correlated with a stronger upregulation of UPR-inducible chaperones, and a higher sensitivity to ER stress-induced cell death. Overexpression of the calcium pump SERCA stimulated calcium release and increased the neurotoxicity observed after exposure of cells to brain-derived infectious PrPRES. Furthermore, expression of PrP mutants that cause hereditary Creutzfeldt-Jakob disease or fatal familial insomnia led to accumulation of PrPRES and their partial retention at the ER, associated with a drastic decrease of ER calcium content and higher susceptibility to ER stress. Finally, similar results were observed when a transmembrane form of PrP was expressed, which is proposed as a neurotoxic intermediate. Our results suggest that alterations in calcium homeostasis and increased susceptibility to ER stress are common pathological features of both infectious and familial PrD models.